Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

B Braun's nerve mapping "pen":

This article was originally published in Clinica

Executive Summary

B Braun has received US FDA 510(k) clearance for its Stimuplex Pen for mapping the location of nerves under the skin, prior to administering anaesthesia. It is thought that the device could improve the efficiency of local anaesthetic administration, making it a more attractive option, particularly in rapid turnover environments. The Stimuplex Pen focuses a very small current from a Stimuplex HNS 11 or HNS 12 nerve stimulator in order to identify nerves up to 3cm beneath the skin.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049460

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel